Back to KRSA

Remedium Capital Partners, LLC → KRSA

Remedium Capital Partners, LLC KRSA Position History

KRSA

Quarters held
1
Latest value
$16.6M
Q3 2026
Peak value
$16.6M
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$16.6M518.5K——

Other funds holding KRSA

Other Remedium Capital Partners, LLC positions

ORKA

Oruka Therapeutics Inc

$149M
SYRE

Spyre Therapeutics Inc

$130M
SYRE

Spyre Therapeutics Inc

$103.3M
SYRE

Spyre Therapeutics Inc

$96.2M
ORKA

Oruka Therapeutics Inc

$92.7M
ORKA

Oruka Therapeutics Inc

$79.5M
APGE

Apogee Therapeutics Inc

$77.9M
ORKA

Oruka Therapeutics Inc

$76.8M